These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 6408664)

  • 21. In vivo receptor binding of the opiate partial agonist, buprenorphine, correlated with its agonistic and antagonistic actions.
    Dum JE; Herz A
    Br J Pharmacol; 1981 Nov; 74(3):627-33. PubMed ID: 6271322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of morphine, naloxone, d,l-cyclazocine, and d-amphetamine on behaviour controlled by a schedule of interresponse time reinforcement.
    Adam-Carrière D; Merali Z; Stretch R
    Can J Physiol Pharmacol; 1978 Oct; 56(5):707-20. PubMed ID: 709412
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clocinnamox antagonism of the antinociceptive effects of mu opioids in squirrel monkeys.
    Pitts RC; Allen RM; Walker EA; Dykstra LA
    J Pharmacol Exp Ther; 1998 Jun; 285(3):1197-206. PubMed ID: 9618423
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antinociceptive actions of morphine and buprenorphine given intrathecally in conscious rats [proceedings].
    Bryant RM; Tyers MB
    Br J Pharmacol; 1979 Jul; 66(3):472P-473P. PubMed ID: 583326
    [No Abstract]   [Full Text] [Related]  

  • 25. Reinforcing properties of buprenorphine: a behavioral analysis.
    Mello NK; Bree MP; Mendelson JH
    NIDA Res Monogr; 1981 Feb; 34():36-42. PubMed ID: 6783946
    [No Abstract]   [Full Text] [Related]  

  • 26. A comparison of the neurochemical effects of buprenorphine with those of morphine and haloperidol in rats.
    Dettmar PW; Cowan A; Walter DS
    Eur J Pharmacol; 1981 Jan; 69(2):147-53. PubMed ID: 7202515
    [No Abstract]   [Full Text] [Related]  

  • 27. Involvement of the median raphe nucleus in antinociception induced by morphine, buprenorphine and tilidine in the rat.
    Bryant RM; Olley JE; Tyers MB
    Br J Pharmacol; 1982 Dec; 77(4):615-24. PubMed ID: 7150869
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of kappa opioids on schedule-controlled behavior of squirrel monkeys.
    Bergman J; Warren PH
    J Pharmacol Exp Ther; 1989 Mar; 248(3):1102-8. PubMed ID: 2539457
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of morphine, methadone, nalorphine and naloxone on responding under schedules of electric shock titration.
    Smith JB; McKearney JW
    J Pharmacol Exp Ther; 1977 Mar; 200(3):508-15. PubMed ID: 403279
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clocinnamox distinguishes opioid agonists according to relative efficacy in normal and morphine-treated rats trained to discriminate morphine.
    Walker EA; Young AM
    J Pharmacol Exp Ther; 2002 Jul; 302(1):101-10. PubMed ID: 12065706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined effects of methamphetamine and morphine on ambulatory activity in mice and continuous avoidance response in rats.
    Kuribara H; Tadokoro S
    Yakubutsu Seishin Kodo; 1985 Sep; 5(3):271-7. PubMed ID: 4072437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stimulus-response relationships in a quickly learned escape from shock: effects of morphine.
    Babbini M; Gaiardi M; Bartoletti M
    Pharmacol Biochem Behav; 1979 Aug; 11(2):155-8. PubMed ID: 504295
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Pharmacological properties of buprenorphine, a new analgesic agent. Part II. (author's transl)].
    Shintani S; Umezato M; Toba Y; Yamaji Y; Kitaura K; Tani T; Ishiyama H; Kikuchi T; Mori T; Nakai S; Watanabe K; Hiyama T
    Nihon Yakurigaku Zasshi; 1982 Mar; 79(3):173-91. PubMed ID: 6123475
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Discriminative stimulus effects of buprenorphine in the rat.
    Holtzman SG
    Psychopharmacology (Berl); 1997 Apr; 130(3):292-9. PubMed ID: 9151365
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A double blind comparison of buprenorphine and morphine in conscious subjects following administration by the intramuscular route.
    Orwin JM; Orwin J; Price M
    Acta Anaesthesiol Belg; 1976; 27(3):171-81. PubMed ID: 1032070
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Fixed-ratio escape and avoidance-escape from naloxone in morphine-dependent monkeys: effects of naloxone dose and morphine pretreatment.
    Downs DA; Woods JH
    J Exp Anal Behav; 1975 May; 23(3):415-27. PubMed ID: 1170272
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Analgesic and narcotic antagonist effects of buprenorphine (author's transl)].
    Hiyama T; Shintani S; Tsutsui M; Yasuda Y
    Nihon Yakurigaku Zasshi; 1982 Mar; 79(3):147-62. PubMed ID: 7084817
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development of tolerance to the analgesic activity of mu agonists after continuous infusion of morphine, meperidine or fentanyl in rats.
    Paronis CA; Holtzman SG
    J Pharmacol Exp Ther; 1992 Jul; 262(1):1-9. PubMed ID: 1625189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Buprenorphine effects on food-maintained responding in Macaque monkeys.
    Mello NK; Bree MP; Lukas SE; Mendelson JH
    Pharmacol Biochem Behav; 1985 Dec; 23(6):1037-44. PubMed ID: 4080772
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The effects of oral morphine and buprenorphine on autotomy following brachial nerve sections in rat.
    Yamamoto T; Mizuguchi T
    Pain; 1991 Dec; 47(3):353-358. PubMed ID: 1784506
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.